 |
The BD Nexiva™ closed IV catheter system, the first-of-its-kind
all-in-one closed system IV catheter, is designed to minimize the risk
of IV catheter failure.
Stabilization
The catheter's built-in stabilization platform minimizes
movement that can lead to catheter complications, restarts and
associated costs, and reduces dislodgement by 84%. The system also meets INS standards and CDC guidelines for catheter stabilization.
Longer dwell times
Proprietary
BD Vialon™ biomaterial enables longer dwell times,2‡ supporting the current Infusion Therapy Standards of Practice for clinically indicated site rotation.3
Integrated system
As an integrated system, the
BD Nexiva system needs fewer add-on devices, minimizing the number of
manipulations that may lead to touch contamination and accidental
disconnections.
Reduced costs
In a 2014 clinical study, it was demonstrated that BD Nexiva
catheters had a low rate of phlebitis and a median dwell time of 144
hours for those in place for 24 hours or more.
6 The longer
dwell times of closed systems led to a cost reduction of approximately
$1M per year per 1,000 beds compared to open systems.
Minimized treatment delays and complications
The BD Nexiva system is power-injection compatible, minimizing the
need to exchange catheter or tubing. Single and dual ports and 18- to
22-G catheters are indicated for use in computed tomography (CT) power
injection. Furthermore, the integrated system prevents leaking at the
catheter-extension set connection.
|
|
|
So easy to use! 
